Or­biMed leads $70M raise for Har­poon Ther­a­peu­tics; Zio­pharm inks com­bo deal with Re­gen­eron's PD-1

Or­biMed has led the syn­di­cate for a $70 mil­lion Se­ries C round for Har­poon Ther­a­peu­tics. The new mon­ey will be put …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.